A rare histone modification, arginine methylation, has been linked to activation of hormone-responsive genes. Interestingly, methylation of a lysine residue in the same histone is present prior to hormone activation, but is excluded from the active loci.
Histone Methylation
Although histone methylation has long been observed in a number of organisms, only recently have specific roles for this modification come to light. The known sites for histone H3 methylation and the enzymes identified are summarized in Figure 1a . The most studied methylation event occurs on Lys9 of histone H3 and is mediated by members of the Su(var)3-9 family of methyltransferases. This family of methyltransferases was originally identified in Drosophila (Su(var)3-9), and homologs have been described in S. pombe (Clr4), mice (Suv39h1 and Suv39h2) and humans (SUV39H1). A characteristic feature of proteins in this family is the presence of a 'SET' domain. Methylation of residue Lys9 of histone H3 is strongly associated with gene silencing and the formation of heterochromatin [1, 2] . This modification creates a binding site for heterochromatin-specific proteins, such as HP1. Interestingly, HP1 also binds to the methyltransferase Su(var)3-9, providing the possibility for feedback regulation as well as for the spread of the H3 Lys9 methylation and HP1 binding to neighboring nucleosomes. Histone H3 Lys9 methylation may also function in repression outside of heterochromatin, as SUV39H1 can cooperate with the Rb protein in repression of euchromatic genes [3] .
Disruption of both mouse genes Suv39h1 and Suv39h2 causes severely reduced viability and chromosome instabilities which lead to increased tumor formation and spermatogenic failure [4] . The chromosomal instability in these mice highlights the importance of this histone modification in the establishment of heterochromatin, and moreover the importance of proper heterochromatin maintenance. Intriguingly, two antibodies specific for Lys9-methylated isoforms of histone H3 were used to characterize the double Suv39h1-h2 mutant mice. One antibody exhibited high specificity towards pericentric heterochromatin and lost reactivity in the double null mice, as expected; the second antibody exhibited a more diffuse staining pattern that was not abolished. These results suggest that additional, unidentified histone methyltransferases can methylate this residue outside of pericentric heterochromatin, suggesting additional functions for histone H3 Lys9 methylation.
Histone H3 can also be methylated at Lys4, but the function of this modification is as yet poorly understood. This modification is associated with the transcriptionally active macronucleus of Tetrahymena [5] . In the fission yeast Schizosaccharomyces pombe, methyl-histone H4 Lys4 is found in euchromatic regions and appears in an exclusive, complementary pattern with methyl-histone H3 Lys9 [6] . A similar relationship is observed at the chicken β-globin locus, where methyl-histone H3 Lys4 is anticorrelated with methylhistone H3 Lys9, but correlates well with histone H3 acetylation [7] .
Interestingly, histone H3 Lys9 methylation has not been detected in the budding yeast Saccharomyces cerevisiae, which has very little heterochromatin, but histone H3 Lys4 methylation is abundant. No Su(var)3-9 family member is readily apparent in the S. cerevisiae genome, but up to six genes (SET1-6) encoding proteins with SET domains have been identified. Set1 methylates histone H3 at Lys4 in vitro, and both SET1 and histone H3 Lys4 methylation are required for complete rDNA silencing [8] . It will be very interesting to determine whether S. cerevisiae uses Lys4 in gene silencing and the formation of heterochromatin-like structures as other organisms use Lys9, or whether the methylation of each of these sites has multiple functions in gene activation and repression. Another family member, Set2, methylates histone H3 Lys36, and appears to have a repressive function in vivo [9] .
Until recently, little was known about the role of arginine methylation of the histones. The significance of this modification has been questionable, because it occurs rarely and is present at very low abundance. However, the discovery of two histone arginine SRC-1, GRIP1, ACTR) . These co-activators recruit secondary coactivators including histone acetylases (p300, CBP) and arginine-specific protein methyltransferases (CARM1, PRMT1). Activation of hormone-responsive genes clearly requires chromatin remodeling and modification, and unraveling the co-factors and identifying the histone modifications involved is a major research focus.
In transient transfection assays with hormoneresponsive reporter genes, multiple co-factors with chromatin modifying activities were found to function synergistically to achieve high levels of transcription. In the presence of a p160 co-activator, for example, CARM1 and p300 function together to yield a higher level of activation than can be achieved by either factor alone [12] . The same is true for CARM1 and PRMT1 [13] . Acetylation of multiple lysines within the core histones by p300 may act cooperatively with methylation of specific arginine residues in H3 by CARM1. Such cooperation appears to be the case for PRMT1. In vitro, PRMT1-methylated histone H4 is a better substrate for the histone acetyltransferase p300 and, conversely, the acetylated tail is a poor substrate for PRMT1 [14] and CARM1 in nuclear receptor responses. They showed that GRIP1 and CARM1 cooperate to enhance hormone-dependent activation of multiple tandemly integrated copies of a CAT reporter gene controlled by the MMTV promoter. Effects of specific mutations showed that the methyltransferase activity of CARM1 is necessary for its co-activator function. CARM1 and the CARM1-methylated form of H3 (methyl Arg17) associated with the MMTV promoter in a hormone-dependent manner. Conversely, methylation of histone H3 Lys4 was found to be excluded from the array upon hormone activation.
Dynamics of Histone Methylation: Is It Reversible?
An exciting implication of these results [19] is that histone methylation is dynamic. No histone demethylating activities have been discovered to date, questioning the reversibility of the modification. Some models suggest that proteolytic cleavage of the histone tails, or replacement of the entire methylated histone, is necessary to remove this mark from chromatin [20] . However, the presence of histone H3 Lys4 methylation in the absence of hormone treatment, the rapid exclusion of this modification upon hormone treatment and the concomitant gain of a new methylation mark a few amino acids downstream (at Arg17) strongly indicate that at least some methylation events are reversible. In this case, proteolysis of the H3 tail would have to be extremely limited to prevent removal of both Lys4 and Arg17. Replacement of the modified 
